GlassScriptPhysician profile
Joshini Simon
NPI 1790312924
$3,024.46
in general payments reported to CMS, 2019-2025
20 companies · $1,401 in 2025
The $1,401 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.55 · 2023: $351 · 2024: $1,247 · 2025: $1,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,731 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,731.00 |
| Education | $267.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $880.77 | 2024-2025 | Ensite, Esprit, Cardiomems |
| Boston Scientific Corporation | $346.75 | 2023-2025 | General - Therapies, Eluvia, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $288.28 | 2024-2025 | Impella |
| Inari Medical, INC. | $286.81 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $239.86 | 2025 | |
| Medtronic, INC. | $199.63 | 2024-2025 | Hawkone, Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $146.36 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.10 | 2023-2025 | Jardiance |
| Cardiovascular Systems INC. | $114.79 | 2023 | Diamondback Coronary |
| Livanova USA, INC. | $108.71 | 2023 | Lifesparc |
| Terumo Medical Corporation | $72.51 | 2024 | Navicross |
| Novo Nordisk INC | $43.76 | 2025 | Wegovy, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $42.17 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $23.96 | 2025 | Opsumit |
| Teleflex LLC | $22.11 | 2025 | Vascband |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.64 | 2024 | Xarelto |
| Philips North America LLC | $17.68 | 2025 | Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $15.02 | 2025 | Farxiga |
| Merck Sharp & Dohme LLC | $14.42 | 2021 | |
| Amgen INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshini Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.